​

Abivax (ABVX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

ABVX Stock Forecast

Abivax (ABVX) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $39.67, with a high of $74.00 and a low of $12.00. This represents a -54.94% decline from the last price of $88.03.

$5 $22 $39 $56 $73 $90 High: $74 Avg: $39.67 Low: $12 Last Closed Price: $88.03

ABVX Stock Rating

Abivax stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

ABVX Price Target Upside V Benchmarks

TypeNameUpside
StockAbivax-54.94%
SectorHealthcare Stocks 13.55%
IndustryBiotech Stocks 49.00%

Price Target Trends

1M3M12M
# Anlaysts-24
Avg Price Target-$53.50$40.25
Last Closing Price$88.03$88.03$88.03
Upside/Downside--39.23%-54.28%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2543---7
Aug, 2543---7
Jul, 25341--8
Jun, 25241--7
May, 25241--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 23, 2025Thomas SmithLeerink Partners$74.00$63.7416.10%-15.94%
Jul 18, 2025Jason ButlerJMP Securities$33.00$10.34219.15%-62.51%
Mar 20, 2025Morgan Stanley$12.00$7.0669.97%-86.37%
Sep 10, 2024Alexander PotterPiper Sandler$42.00$11.99250.29%-52.29%
May 20, 2024Julian HarrisonBTIG$43.00$13.64215.25%-51.15%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 23, 2025Leerink PartnersOutperformOutperformhold
Jul 18, 2025CitigroupMarket OutperformMarket Outperformhold
Sep 10, 2024Piper SandlerOverweightOverweighthold
Jul 29, 2024LaidlawBuyinitialise
May 20, 2024BTIGBuyinitialise

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.47$-3.13$-2.35-----
Avg Forecast$-2.83$-2.55$-1.98$-2.73$-2.63$-2.32$-1.53$-0.52
High Forecast$-1.53$-0.86$-1.79$-2.57$-2.34$-0.79$-0.52$-0.18
Low Forecast$-4.43$-4.15$-2.15$-2.92$-2.98$-3.78$-2.50$-0.85
Surprise %-12.72%22.75%18.69%-----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$37.00K-------
Avg Forecast$649.45K$1.65M$431.20K$7.27M$5.53M$3.83M$134.18M$283.42M
High Forecast$933.47K$2.44M$447.40K$9.31M$8.20M$5.68M$199.08M$420.53M
Low Forecast$420.50K$809.12K$414.09K$6.21M$2.72M$1.88M$65.96M$139.34M
Surprise %-94.30%-------

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.36M$-69.85M$-147.40M-----
Avg Forecast$-121.73M$-109.67M$-85.06M$-117.57M$-113.10M$-100.04M$-66.03M$-22.59M
High Forecast$-65.94M$-37.19M$-77.30M$-110.73M$-100.84M$-33.92M$-22.39M$-7.66M
Low Forecast$-190.93M$-178.65M$-92.47M$-125.63M$-128.52M$-162.95M$-107.56M$-36.80M
Surprise %-66.03%-36.32%73.29%-----

ABVX Forecast FAQ

Is Abivax stock a buy?

Abivax stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Abivax is a favorable investment for most analysts.

What is Abivax's price target?

Abivax's price target, set by 6 Wall Street analysts, averages $39.67 over the next 12 months. The price target range spans from $12 at the low end to $74 at the high end, suggesting a potential -54.94% change from the previous closing price of $88.03.

How does Abivax stock forecast compare to its benchmarks?

Abivax's stock forecast shows a -54.94% downside, underperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the biotech stocks industry (49.00%).

What is the breakdown of analyst ratings for Abivax over the past three months?

  • September 2025: 57.14% Strong Buy, 42.86% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 57.14% Strong Buy, 42.86% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 37.50% Strong Buy, 50.00% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Abivax’s EPS forecast?

Abivax's average annual EPS forecast for its fiscal year ending in December 2024 is $-2.73, marking a 16.17% increase from the reported $-2.35 in 2023. Estimates for the following years are $-2.63 in 2025, $-2.32 in 2026, $-1.53 in 2027, and $-0.52 in 2028.

What is Abivax’s revenue forecast?

Abivax's average annual revenue forecast for its fiscal year ending in December 2024 is $7.27M, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $5.53M, followed by $3.83M for 2026, $134.18M for 2027, and $283.42M for 2028.

What is Abivax’s net income forecast?

Abivax's net income forecast for the fiscal year ending in December 2024 stands at $-118M, representing a -20.23% decrease from the reported $-147M in 2023. Projections indicate $-113M in 2025, $-100M in 2026, $-66.034M in 2027, and $-22.591M in 2028.